DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Ross AM, Molhoek P, Lundergan C. et al; HART II Investigators.
Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).
Circulation 2001;
104 (06) 648-652
We do not assume any responsibility for the contents of the web pages of other providers.